Clinical impact of peripheral attacks in hereditary angioedema patients

American Journal of Medicine

Volumn 125, Issue 9, 2012, Pages

  Kusuma, Andy ^a   Relan, Anurag ^b   Knulst, André C ^a   Moldovan, Dumitru ^c   Zuraw, Bruce ^d   Cicardi, Marco ^e   Levy, Robyn J ^f   Nuijens, Jan H ^b   Hack, C Erik ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Pharming Group NV   (Netherlands)

^c UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF MILAN   (Italy)

^f Family Allergy and Asthma Center PC   (United States)

Author keywords

Dysfunction; Hereditary angioedema; Pain; Peripheral attacks; Swelling

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; PLACEBO;

ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PERIPHERAL EDEMA; PERIPHERAL SWELLING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; TREATMENT RESPONSE; VISUAL ANALOG SCALE;

ADOLESCENT; ADULT; ANGIOEDEMAS, HEREDITARY; COMPLEMENT C1 INACTIVATOR PROTEINS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84865689861     PISSN: 00029343     EISSN: 15557162     Source Type: Journal    
DOI: 10.1016/j.amjmed.2011.12.016     Document Type: Article

References (28)

1. B.J. Zuraw Hereditary angioedema N Engl J Med 359 2008 1027 1036
2. A. Agostoni, E. Aygören-Pürsün, K.E. Binkley Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond J Allergy Clin Immunol 114 3 Suppl 2004 S51 S131
3. A. Agostoni, M. Cicardi Hereditary and acquired C1-inhibitor deficiency: biological and clinical characteristics in 235 patients Medicine (Baltimore) 71 1992 206 215
4. U.C. Nzeako, E. Frigas, W.J. Tremaine Hereditary angioedema: a broad review for clinicians Arch Intern Med 161 2001 2417 2429
5. F.S. Rosen, C.A. Alper, J. Pensky Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema J Clin Invest 50 1971 2143 2149
6. E. Pappalardo, S. Caccia, C. Suffritti Mutation screening of C1 inhibitor gene in 108 unrelated families with hereditary angioedema: functional and structural correlates Mol Immunol 45 2008 3536 3544
7. J. Nussberger, M. Cugno, M. Cicardi Bradykinin-mediated angioedema N Engl J Med 347 2002 621 622
8. E.D. Han, R.C. MacFarlane, A.N. Mulligan Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor J Clin Invest 109 2002 1057 1063
9. M. Cicardi, A. Banerji, F. Bracho Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema N Engl J Med 363 2010 532 541
10. F. Bossi, F. Fischetti, D. Regoli Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency J Allergy Clin Immunol 124 2009 1303 1310
11. M.J. Prematta, J.G. Kemp, J.G. Gibbs Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks Allergy Asthma Proc 30 2009 506 511
12. K. Bork, K. Siedlecki, S. Bosch Asphyxiation by laryngeal edema in patients with hereditary angioedema Mayo Clin Proc 75 2000 349 354
13. K. Bork, S.E. Barnstedt Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema Arch Intern Med 161 2001 714 718
14. K. Bork, G. Meng, P. Staubach, J. Hardt Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema Transfusion 45 2005 1774 1784
15. M.M. Gompels, R.J. Lock, M. Abinun C1 inhibitor deficiency: consensus document Clin Exp Immunol 139 2005 379 394
16. K. Bork, G. Meng, P. Staubach, J. Hardt Hereditary angioedema: new findings concerning symptoms, affected organs, and course Am J Med 119 2006 267 274
17. K. Bork, P. Staubach, J. Hardt Treatment of skin swellings with C1-inhibitor concentrate in patients with hereditary angio-oedema Allergy 63 2008 751 757
18. J.H. Nuijens, C.E. Hack Recombinant C1 inhibitor J Allergy Clin Immunol 114 2004 S100 S104
19. M.B.A. Van Doorn, J. Burggraaf, T. van Dam A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema J Allergy Clin Immunol 116 2005 876 883
20. G. Choi, M.R. Soeters, H. Farkas Recombinant human C1-inhibitor in the treatment of acute angioedema attacks Transfusion 47 2007 1028 1032
21. B. Zuraw, M. Cicardi, R.J. Levy Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema J Allergy Clin Immunol 126 2010 821 827
22. M. Berrettini, B. Lämmle, T. White Immunoblotting analysis of high molecular weight kininogen in human plasma using murine monoclonal antibodies Blood 68 1986 455 462
23. A. Williamson, B. Hoggart Pain: a review of three commonly used pain rating scales J Clin Nurs 14 2005 798 804
24. K.H. Todd, K.G. Funk, J.P. Funk, R. Bonacci Clinical significance of reported changes in pain severity Ann Emerg Med 27 1996 485 489
25. E.J. Gallagher, P.E. Bijur, C. Latimer, W. Silver Reliability and validity of a visual analog scale for acute abdominal pain in the ED Am J Emerg Med 20 2002 287 290
26. S.L. Collins, R.A. Moore, H.J. McQuay The visual analogue pain intensity scale: what is moderate pain in millimetres? Pain 72 1997 95 97
27. B. Lämmle, B. Zuraw, M.J. Heeb Detection and quantitation of cleaved and uncleaved high molecular weight kininogen in plasma by ligand blotting with radiolabeled prekallikrein or factor XI Thromb Haemost 59 1987 151 161
28. C.E. Hack, A. Relan, E.S. van Amersfoort Target levels of functional C1-inhibitor in hereditary angioedema Allergy 67 1 2012 123 130